New MRI technique may eliminate need for contrast dye in brain tumor screening
NCT ID NCT04113408
First seen Jan 11, 2026 · Last updated Jun 15, 2026 · Updated 27 times
Summary
This study tested whether special MRI sequences (FABIR) can spot meningiomas without using gadolinium contrast, which can build up in the body after many injections. Researchers compared the new method to standard contrast MRI in 315 adults undergoing screening or follow-up for meningioma. If successful, this approach could reduce risks for patients who need repeated scans, such as those on certain long-term medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondation ophtalmique Adolphe de Rothschild
Paris, Paris, 75019, France
Conditions
Explore the condition pages connected to this study.